Assignee
ADELMAN DANIEL C
US·3 granted patents·3 pending applications·14 citations·filing 2005–2012
Top patents by PatentIndex Score
6 records- 0191US8124773B21,8-naphthyridine compounds for the treatment of cancerADELMAN DANIEL C·Filed 2007·Granted Feb 28, 2012·10 cites·13 claims
- 0283US8580814B2Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancerADELMAN DANIEL C·Filed 2006·Granted Nov 12, 2013·3 cites·24 claims
- 0376US8765954B21,8-naphthyridine compounds for the treatment of cancerADELMAN DANIEL C·Filed 2012·Granted Jul 1, 2014·1 cites·8 claims
- 0457US2006025437A1SNS-595 and methods of using the sameADELMAN DANIEL C·Filed 2005·Application pending·0 cites
- 0553US2008063642A1Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disordersADELMAN DANIEL C·Filed 2007·Application pending·0 cites
- 0645US2014248251A1Methods and Pharmaceutical Compositions for Treating Celiac Disease and Gluten IntoleranceADELMAN DANIEL C·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →